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The expression of antigenic determinants on the mouse embryo has been the 
subject of a number of investigations in recent years. Identification of these cell 
surface products of specific genetic loci is important for an understanding of the 
complex immunological interrelationships  now  known  to  exist  between  the 
maternal and fetal organisms (1, 2), for their use as markers in the analysis of 
tissue interactions in embryogenesis, and as indicators of gene activity during 
differentiation. 
Earlier  studies  employing both  transplantation  and  in  vitro  assays  have 
demonstrated the presence of alloantigenic determinants from the two-cell stage 
(3-6).  However,  the mouse strain  combinations used in  these investigations 
differed both at the major (H-2) and minor (non-H-2) histocompatibility loci, and 
recent attempts have been directed towards a more precise characterization of 
these alloantigens. Immunofluorescence  (7, 8), mixed antiglobulin, mixed agglu- 
tination (9), cytotoxicity (10), and transplantation (11) tests have all so far failed 
to detect H-2 alloantigens on the preimplantation embryo. These determinants 
have been reported to arise only in the postimplantation period, on putative 
inner cell mass cells present in blastocyst outgrowths developing in vitro (12), 
and on the embryonic, but  not the trophoblastic,  component of the  71/2-day 
conceptus (13). In contrast, non-H-2 antigens have been detected on all cleavage 
stages and on blastocysts by a variety of techniques, including cytotoxicity (10), 
indirect immunofluorescence (7, 8), and ectopic transplantation (11,  14). 
Despite  these  studies  there  are  many issues  still  to  be  resolved.  Further 
information is required on the precise nature and surface distribution of the 
alloantigens, and it is not yet clear whether the failure to detect H-2 reflects a 
true absence of these determinants or a  lack of sensitivity of the techniques 
employed. In view of the apparent lack of antigenicity of the postimplantation 
ectoplacental cone trophoblast (15),  a  particularly crucial point to establish is 
the  extent  to  which the  outer  layer of the  preimplantation  blastocyst,  the 
trophectoderm, displays antigenic properties and how these change during its 
subsequent differentiation at the time of implantation in the allogeneic environ- 
ment of the uterus. 
* This work was supported by The Rockefeller Foundation. 
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This communication reports the use of a  sensitive immunoperoxidase tech- 
nique,  which allows examination of the cell membrane at the ultrastructural 
level, in an analysis of H-2 and non-H-2 antigen expression on cleavage stage 
embryos and during early trophoblast differentiation in the mouse. 
Materials and Methods 
Mice.  The following inbred strains of mice were used: A(H-2~),  C57BL(H-2b),  C3H/He-mg {/-/- 
2k),  C57Br/cd(/-/-2k),  B10.Br(H-2k),  and  C57BL/10ScSn  (/-/-2b). In  differing  combinations  these 
animals provided embryonic material  and  antisera  with major (H-2), minor (non-H-2),  or com- 
bined (H-2 plus non-H-2) histocompatibility antigen differences. 
Antisera 
The procedure for production of antisera differed slightly in each of the three mouse combina- 
tions employed: 
COMBINED S-2  AND NON-H-2.  Adult male  C57BL mice received two consecutive full-thick- 
ness skin grafts followed by four weekly intraperitoneal injections of 5  x  107 spleen cells from A 
strain donors. Animals were bled 6 days after the last injection, and the antisera were tested by 
hemagglutination. 
NON-H-2.  Adult C57Br mice were immunized against C3H tissues by one tail skin graft and 
six  weekly  intraperitoneal  injections of 2  x  107  spleen  and  lymph  node  cells.  Antisera  were 
collected 7 days later and assayed for cytotoxicity against C3H lymphocytes. 
H-2.  C57BL/10ScSn recipients were immunized against  the congenic strain  B10.Br by five 
intraperiteneal injections of 2 ×  107 spleen and lymph node cells at 10-day intervals followed by a 
single booster  injection of 7  x  107 cells.  Antisera  were collected 7 days  later and  assayed  for 
cytotoxicity against B10.Br lymph node cells. 
Embryonic Material 
Spontaneously ovulating female mice were caged with males overnight and examined for the 
presence of a vaginal plug the following morning. The day of plug detection was designated day 0 
of pregnancy.  Several stages  of embryonic development from  both  pre-  and  postimplantation 
pregnancy were examined: 
PREIMPLANTATION EMBRYOS.  These  were flushed from the reproductive tract  in  phosphate- 
buffered saline  (PBS) 1 with 2% bovine serum albumin (BSA).  Eight-cell stages were recovered 
from the oviducts on day 2 postcoitum (pc); morulae from the uterus on day 3 pc.; blastocysts from 
the uterus on day 31/2 pc. The zona pellucida was routinely removed from the embryos by partial 
digestion with 0.5% pronase in PBS followed by mechanical disruption by repeated withdrawal 
into a glass micropipette. This latter procedure was carried out in pronase-free PBS to minimize 
exposure to the enzyme. In some cases zona removal was effected entirely by mechanical disrup- 
tion. 
PERI-IMPLANTATION EMBRYOS.  To  assess  the  antigenic  status  of the  embryo in  the  critical 
period approaching and immediately after attachment to the maternal tissues two experimental 
procedures were adopted. Groups of pregnant females were bilaterally ovariectomised at day 21/2 
pc and  given subcutaneous  injections of 1-mg progesterone  (Organon)  in 0.1  ml arachis  oil on 
alternate days for periods up to 10 days. This procedure prevents the blastocysts from implanting 
and maintains  them in a  state of experimentally controlled delay until activated to implant by 
subcutaneous adminstration of 0.1  ~Lg 17-B-oestradiol (Organon Laboratories, Scotland) in 0.1 ml 
PBS (16). Removal of the blastecysts 18 h  after oestrogen treatment allowed examination of the 
embryos at a time closely approaching implantation. 
Since recovery of the embryo in the immediate postimplantation period is at present impracti- 
cal and to examine implantation-associated changes in the trophoblast in the absence of complicat- 
ing maternal  factors,  use was made  of the  ability of blastocysts to 'implant' and  produce  out- 
growths in vitro. This is considered to be analogous to the initial stages of implantation in utero 
1Abbreviations  used  in  this paper:  DAB,  diaminobenzidine;  FCS,  fetal  calf serum;  HRP, 
horseradish  peroxidase; ICM, inner cell mass;  PBS, phosphate-buffered  saline; pc,  postcoitum; 
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(17).  Zona-free blastocysts were transferred to RPMI culture medium plus 10% fetal calf serum 
(FCS) in Cooke microtitre plates (Cooke Laboratory, Alexandria, Va.) and maintained under 5% 
CO2 in air for 3-4 days.  During this period the blastocysts attached to the bottom of the culture 
vessel and produced outgrowths of trophoblastic cells together with some overlying cells derived 
from the inner cell mass. 
POSTIMPLANTATION TISSUES.  Entire conceptuses were dissected from the decidual shells of the 
71/2-day pregnant mouse uterus, placed in PBS and separated into ectoplacental cone trophoblast 
and embryonic sac (18).  Care was taken to remove maternal decidual cells and Reichert's mem- 
brane surrounding the embryonic sac. 
Peroxidase Labeling.  This was performed in two ways. Initial studies were carried out using a 
method involving direct coupling of horseradish peroxidase (HRP} (Type VI, Sigma Chemical Co., 
St. Louis, Mo.) to the immunoglobulin fraction of C57BL anti-A antiserum with glutaraldehyde as 
the  cross-linking  agent  according  to  the  method  of Avrameas  (19).  A  strain  embryos  were 
maintained in RPMI plus 10% FCS at room temperature in the presence of 0.02 M sodium azide for 
15  min  and  then  cooled  on  ice  for  10  min  before  the  addition  of ice-cold  peroxidase-labeled 
antiserum to a  dilution of 1:10 and futher incubation for 1 h  at 0°C.  The azide was employed to 
inhibit nonspecific uptake of label by pinocytosis (20).  The embryos were washed extensively in 
PBS, fixed for 1 h  in 2.5% glutaraldehyde in PBS, rewashed, and then incubated with a  freshly 
saturated solution of 3,3'-diaminobenzidine (DAB, 0.3 mg m1-1)  and 0.01%  H202 in 0.5 M  Tris- 
HC1 (pH 7.6) for 10-15 min at room temperature (21). After final washing the embryos were proc- 
essed for electron microscopy as described below. C57BL embryos of equivalent stages were car- 
ried through in parallel as controls. 
The  remainder of the  experiments  were  carried  out using  an  indirect peroxidase-labeling 
technique.  Rabbit  antimouse  immunoglobulin antiserum  (RaMIg)  was  raised  by  immunizing 
rabbits by intramuscular injections of nonimmune mouse serum immunoglobulin emulsified in 
Freund's complete adjuvant. The immunoglobulin fraction was isolated from the RaMIg serum by 
ammonium sulphate precipitation and coupled with HRP as'above. The precise conditions for the 
test varied with the alloantiserum used. With the C57BL anti-A and the C57Br anti-C3H antisera, 
the embryos were treated as above and incubated in ice-cold antiserum diluted 1 in 10 for 1 h, 
whereas the dilution of the C57BL/10ScSn anti-B10.Br antiserum was found to be optimal at 1 in 5. 
Embryos were then washed extensively, incubated with RaMIg-peroxidase conjugate for 1 h  at 
0°C,  washed, and fixed for 1 h  in 2.5% glutaraldehyde in PBS. After further washing the reaction 
for peroxidase activity was performed as described above for the direct labeling procedure. 
The following controls were carried out in parallel as indicators for nonspecific reactivity: (a) 
embryos syngeneic with the strain in which the antiserum had been raised,  (b) incubation of 
embryos in nonimmune serum, and (c) incubation with RaMIg-peroxidase conjugate alone. 
Electron Microscopy.  After treatment, preimplantation mouse embryos were deposited into a 
drop of molten 2% agar in PBS on a  slide at 38-40°C. The agar was allowed to gel,  and a  small 
block containing the embryos was cut out for subsequent processing.  In this form the embryos 
were postfixed in ice-cold 1% osmium tetroxide for 1 h, dehydrated, and embedded in Epon 812. 
Except  for  the  substitution  of a  1:1  alcohol:Epen  solution  for  propylene  oxide,  btastocyst 
outgrowths in microtitre wells were similarly postfixed and dehydrated and then embedded by 
addition of Epon directly into the well. After hardening of the Epen the plastic well was trimmed 
away to allow sectioning of the block. Postimplantation tissues were processed using conventional 
methods. 
In most cases sections were not counterstained with lead tartrate or uranyl acetate since this 
was found to interfere with the high contrast between the 3,3'-DAB reaction product and the tissue 
background.  Sections were examined in a  Philips EM300 electron microscope (Philips Electronic 
Instruments, Mount Vernon, N. Y.) at an accelerating voltage of 80kV. 
Results 
Preimplantation Embryos.  Visualization of surface antigenic determinants 
by binding of the electron-dense  peroxidase  conjugate  was  similar  on all  the 
preimplantation embryos where non-H-2 antisera and combined H-2 and non-H- 
2 antisera  were  employed (Table  I).  The pattern  of labeling  on the eight-cell, SEARLE,  SELLENS,  ELSON,  JENKINSON,  AND  BILLINGTON 
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Alloantisera  Antigenic differ- 
ence 
Postimplanta- 
Preimplantation  Peri-implantation  tion (71/2  days) 
Blastocyst out-  Ecto- 
Acti-  growth in vitro  Embry-  placen- 
Eight-  Blasto-  vated  onic  tal 
cell  Morula  cyst  blaste-  cone 
cyst  ICM  Tropho-  sac  blast  tropho- 
blast 
C57BL anti-A 
Direct labeling  H-2 plus non-H-  + +  + +  + +  NT  NT  NT  + +  - 
2 
Indirect labeling  ++  ++  ++  ++/-°  ++  -  NT  NT 
C57BR/cd  anti-C3H  H-2 plus non-  + +  + +  + +  + +/-  °  + +  -  NT  NT 
(indirect  label-  H-2 
ing) 
C57BL/10ScSn  anti-  H-2 only  -  NT  +  NT  + +  -  + +  - 
B10.BR.  (indi- 
rect labeling) 
+ +, heavily labeled;  +, sparsely labeled;  -, unlabeled; NT, not tested; °, labeling on activated blastocysts  varied 
from heavily to unlabeled cells. 
* Assessment based upon 5-15 embryos for each treatment. 
morula, and 31/2-day  blastocyst  was uniform and continuous over the  cell  surface 
(see  Fig. 1). All controls were completely unlabeled. With the H-2 antisera, of 
the two stages of  embryo examined, the eight-cell  and blastocyst,  only the latter 
showed labeling,  but  to  a uniformly lesser  intensity  than with the other antisera 
(Fig.  2).  This would appear to  reflect  a quantitative difference  in the levels  of  H- 
2 antigen expressed at this  time, a finding of  particular interest in view of  the 
inability  of  all previously reported techniques to detect these determinants (see 
Discussion). 
The occurrence of  peroxidase-containing  pinocytotic vesicles  immediately be- 
neath the cell-surface,  which was commonly observed when the labeling proce- 
dures were initially  performed at room temperature, was prevented by incuba- 
tion on ice in the presence of sodium  azide. The only nonspecific labeling 
observed was on the cell  surfaces lining the blastocoelic  cavity, reflecting  the 
ability  of  the  blastocyst  to  accumulate macromolecules and the  ineffectiveness  of 
the washing procedures at this  site. 
Peri-implantation Embryos 
OESTROGEN-ACTIVATED DAY I0 BLASTOCYSTS.  Blastocyst  s  recovered from the 
uterus after a  10-day period of experimentally-induced delay showed a  signifi- 
cant and consistent reduction in the degree ofperoxidase labeling with both the 
non-H-2 and the combined H-2 and non-H-2 alloantisera. Normal 31/2-day blasto- 
cysts were all heavily labeled, and all controls were negative. 
The  distribution  of the  label  on  the  blastocyst cell  surface  varied  from  a 
complete absence on some trophectoderm cells (Fig.  3) to a  discontinuous but 
distinct labeling on other cells. The position of the labeled cells bore no apparent 
relation to the polarity of the activated blastocyst. It is clear that antigen  loss 
occurs as the time for blastocyst implantation  approaches. FIG.  1.  Electronmicrographofthecellsurfaceofa31/2-dayAstrainmouseblastocystafter 
immunoperoxidase treatment with antiserum directed against combined H-2 and non-H-2 
antigens.  The trophectederm is covered by a  continuous and heavy deposit of peroxidase 
conjugate,  x  40,000.  (Inset)  Unlabeled  surface of C57BL control  blastocyst  after similar 
treatment,  x  40,000. 
Fro.  2.  B10.  Br blastocyst  after immunoperoxidase treatment  with antiserum  directed 
against H-2 antigen only. The labeling is discontinuous and less dense by comparison with 
that seen in Fig.  1.  ×  40,000. 
Fro.  3.  A strain blastocyst 18 h after experimentally-induced activation. The labeling has 
disappeared completely, indicating antigen loss at the time of implantation,  x  40,000.  (c.f. 
Fig. 1). 
352 FIG.  4.  In vitro outgrowth  of C3H  blastocyst after treatment with antiserum directed 
against non-H-2 antigens. The micTograph shows the surface of a cell derived from the inner 
cell mass of the blastocyst, with extensive labeling,  x  14,000. 
Fro.  5.  Trophoblastic component of the same outgrowth as in Fig. 4, showing the complete 
absence of label on this cell type.  x  40,000. 
FIG.  6.  (a) The highly mic~ovillous cell surface of a  71/s-day A strain embryonic sac after 
treatment  with  antiserum  directed  against  combined  H-2  and  non-H-2  antigens.  The 
labeling on this tissue is extremely dense, and occurs also in the cytoplasmic vesicles. (b) 
Unlabeled surface of control C57BL embryonic sac. Both ×  40,000. 
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BLASTOCYST OUTGROWTHS IN VITRO.  Blastocysts cultured in vitro for 3 days 
formed an outgrowth of trophoblastic cells derived from the trophectoderm and 
an overlying group of smaller cells presumably of inner cell mass origin. These 
two cell types displayed a striking difference  in their surface labeling properties 
after incubation with the various antisera. The embryonic cells were densely 
labeled with continuous deposits of poroxidase (Fig.  4), while the trophoblastic 
cells were always entirely unlabeled (Fig.  5). The use of the outgrowth model 
thus provided a  means of examining the early stages of differentiation of the 
trophoblast and provided further evidence for the loss of demonstrable antigenic 
determinants at this critical stage in the implantation process. 
POSTIMPLANTATION CONCEPTUS.  Examination of the two main components of 
the 71/2-day mouse conceptus, the ectoplacental cone trophoblast and the embry- 
onic sac, confirmed the differential antigenic status indicated by the results of 
the blastocyst outgrowth study (Table I). The embryonic sac, derived from the 
inner cell mass, possesses an outer endodermal layer that was densely labeled 
after antiserum treatment (Fig. 6). It was also noted that those endedermal cells 
situated on the lateral walls of the sac showed evidence of peroxidase label 
within large cytoplasmic vesicles, whereas those at the posterior tip of the sac 
did not. The cells at the tip were lacking in any obvious cytoplasmic vacuole 
activity and possessed few cell surface microvilli. In all control embryos the cell 
surface was unlabeled. 
In contrast to the embryonic cells, the trophoblastic cells on the outer regions 
of the ectoplacental cone showed no evidence of peroxidase labeling in either 
experimental or control groups. With the present technique no conclusions can 
be drawn about the antigenic status of any cells within the central portion of the 
ectoplacental cone. Although the lack of staining of any of the trophoblastic cells 
of the blastocyst outgrowths might argue to the contrary, it has been suggested 
that there may be two distinct populations of cells in the ectoplacental cone with 
differing antigenic properties (22). Immunoporoxidase tests on cone outgrowths 
in vitro or on sectioned material could resolve this point. 
Discussion 
The results of these investigations confirm earlier reports (7, 8,  10) that the 
cleavage stage mouse embryo expresses minor histocompatibility antigens (non- 
H-2), but not those determined by the major locus (H-2). In marked contrast to 
previous studies, however, H-2 as well as non-H-2 antigens have been found on 
the trophectoderm of the ensuing stage of development, the preimplantation 
blastocyst, although the pattern of labeled antiserum binding observed suggests 
that the expression of these H-2 antigens is relatively weak at this stage. The 
discrepancy between the present findings and those of previous workers using 
immunofluorescence probably reflects the  greater resolution of the  electron 
microscopical immunoperoxidase technique, and it might be expected that other 
indicators of appropriate sensitivity, such as radiolabeled antisera, would also 
reveal the presence of these antigens on the blastocyst. Similarly, low antigen 
levels, as well as the transient nature of their appearance on the trophectoderm 
(see  below),  may explain the failure to  detect H-2  antigens in  experiments 
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The present detection of H-2 antigens on the trophectoderm of the preimplan- 
tation blastocyst represents the earliest stage at which these products of the H-2 
locus  have been demonstrated on  the fertilized mouse embryo. It has  been 
reported that H-2 antigens can be identified on the unfertilized mouse ovum 
(23), but it would appear that as cleavage proceeds these are either diluted out or 
lost, and that further H-2 antigens do not appear in detectable levels until the 
blastocyst stage is reached, suggesting a differential activity on the part of genes 
controlling H-2 and non-H-2 antigen expression before this time. At present, 
however, it is unclear whether the apparent lack of H-2 antigens on the cleavage 
stages is due to the complete repression of their synthesis or whether they are 
produced but in some way fail to be expressed, possibly as a  result of being 
synthesized in an incomplete form. Recent reports have suggested that certain 
antigens present on at least some forms of teratoma, and also detectable on the 
preimplantation embryo, have a  reciprocal relationship with H-2  antigen in 
their expression on the cell surface and disappear by the time H-2 becomes 
detectable on the postimplantation embryo, implying that they may be precur- 
sors of the complete H-2 molecule (24). So far the validity of this hypothesis and 
the  level  at  which the  switchover from precursor to  definitive H-2  antigen 
synthesis is effected remains to be established. 
As far as the postimplantation stages are concerned, transplantation and in 
vitro cytotoxicity tests using embryos explanted at 71/2 days have shown that a 
differential antigenicity exists  between the  trophoblast  of the  ectoplacental 
cone, which appears to have no detectable antigens, and the inner cell mass 
(ICM)-derived egg cylinder, which expresses H-2 and non-H-2 antigens (15, 25, 
26). In all these studies the actual developmental age of the tissues at the time of 
antigen detection is difficult to determine because of the possibility of continued 
differentiation between the time of explantation and the time of assessment. 
The results  of the present investigation, however, clearly indicate that  the 
differential antigenicity of the trophoblastic and embryonic components of the 
conceptus, with respect to both H-2 and non-H-2, exists at the 71/2-day stage. 
The precise time of appearance of H-2 antigens on the embryonic derivatives 
of the inner cell mass has yet to be established. Experiments involving ectopic 
transplantation of postimplantation embryos have suggested that these anti- 
gens are not present on the 6-day egg cylinder, but arise 1-11/2 days later (13). 
This  is  substantially in  agreement with  the  immunofluorescence studies  of 
Heyner (12) showing that  H-2  is  first  detectable on  putative  ICM  cells  of 
blastocysts  that  have been allowed to  'implant'  and continue their  development 
in  vitro  to a stage considered to  be equivalent to  day 61/2  in  utero.  It  remains to 
be seen whether the low levels of H-2 detectable on the trophectoderm by 
immunoperoxidase are  also  present  on  the  ICM at  the  blastocyst  stage.  Examina- 
tion of ICM's isolated by microdissection to ensure adequate exposure to the 
labeled antisera should resolve this  point.  At whatever time H-2 antigens first 
appear, however, it is apparent that their  expression only increases to more 
readily detectable levels  with the onset of  the rapid processes of  differentiation 
and embryogenesis which are not initiated  until  implantation is  established. 
In view of the apparent lack of antigens (both H-2 and non-H-2) on the 
postimplantation ectoplacental  cone trophoblast,  as  compared to  the  preimplan- 356  ALLOANTIGENS  IN  EARLY  MOUSE  DEVELOPMENT 
tation trophectoderm, it would seem that during the course of its differentiation 
antigen expression on the trophoblast is in some way abolished. As indicated by 
the comparison of preactivated blastocysts with those activated to implant in 
vivo or allowed to 'implant' in vitro, this antigen loss occurs concurrently with 
the  initiation  of implantation,  a  finding consistent  with  a  recent report  on 
changes in  specific antibody-binding to the blastocyst at implantation as as- 
sessed by mixed hemadsorption and isotope antiglobulin techniques (27). The 
precise mechanism by which this antigen loss takes place remains uncertain, 
although the in vitro experiments suggest that the process is intrinsic to the 
blastocyst and not necessarily dependent upon maternal factors. At the time of 
implantation the cells of the trophectoderm undergo considerable modification, 
including increasing polyploidy (28), the acquisition of marked phagocytic prop- 
erties  (29), and  changes  in  ultrastructure  indicative  of increased  metabolic 
activity (30), in membrane ultrastructure (31) and in membrane glycoproteins  2. 
It seems reasonable to consider that the loss of surface antigens may be related 
to these extensive alterations in the physiology and membrane properties of the 
trophoblast. 
In  biological  terms  the  disappearance  of trophoblast  surface  antigens  at 
implantation could be highly advantageous with respect to the survival of the 
fetal allograft. During its early development the embryo is enclosed within the 
zona pellucida which, although it may be permeable to antibody (32),  should 
provide an effective barrier to immunologically competent maternal cells.  At 
implantation, however, this acellular coat is shed and the blastocyst attaches to 
the uterine epithelium which soon degenerates, allowing close contact of the 
trophoblast with the uterine stroma and maternal blood elements. Under these 
conditions the ability of the embryo to present an outer surface deficient in 
antigens, at a time when antigen expression on the inner cell mass is probably 
increasing,  should  reduce  the  possibilities  of recognition  or  immunological 
attack by the maternal  immune system.  In  this  way it  may be possible  to 
explain the ability of the fetal allograft to establish itself during the crucial 
period  when other protective  mechanisms,  e.g.  serum blocking  factors,  are 
unlikely to be operative and when, being relatively small, the embryo would be 
easily overwhelmed by a maternal immune response. 
It should also be noted that the presence of histocompatibility antigens on the 
preimplantation embryo, particularly those of the major H-2 complex, may have 
implications for the immunological manipulation of early pregnancy, especially 
in view of the evidence that paternal antigens are expressed during these stages 
of development (8). In as much as the appearance of antigens on those compo- 
nents of the embryo directly exposed to the maternal environment is relatively 
transient, however, the time when such interference is possible may be strictly 
limited. In this respect further information on the immunological status of the 
uterine environment in both the pre- and peri-implantation periods is required, 
especially in those species, such as man, where implantation is of the intimate 
interstitial type. 
2 Jenkinson, E. J., and R. F. Searle. 1976. Cell surface changes on the mouse blastocyst at 
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Summary 
An immunoperoxidase-labeling technique allowing visualization of antibody 
binding to the cell surface at the electron microscopical level has been employed 
in an analysis of H-2 and non-H-2 alloantigen expression on the early mouse 
embryo. The presence of non-H-2 antigenic determinants has been confirmed on 
eight-cell, morula, and blastocyst stages of development. Contrary to previous 
reports,  however,  low  levels of H-2  antigen have  also been  detected on  the 
blastocyst.  This  is  the  earliest  stage  at  which  H-2  has  been  shown  to  be 
expressed on the fertilized mouse egg and may reflect the greater resolution of 
the immunoperoxidase technique. 
Using two  different models to  study the critical peri-implantation stages, 
those of experimentally induced blastocyst activation and blastocyst outgrowth 
in vitro, it has been demonstrated that antigen loss occurs on the trophectoderm 
at the time of implantation, and that this is not necessarily dependent upon 
maternal influence. It is suggested that the loss may be an important factor in 
the prevention of maternal immune rejection during the establishment of the 
fetal allograft. 
The two major components of the early postimplantation conceptus display a 
striking differential in antigenic status. The embryonic sac shows a high degree 
of peroxidase labeling, while the ectoplacental cone trophoblast is unlabeled. 
These findings add support to the concept of antigenic neutrality of the early 
trophoblast and its role in the maintenance of a normal fetomaternal immuno- 
logical equilibrium. 
We are indebted to Dr. Martin Johnson for the gift of the non-H-2 antiserum and to Mrs. Ruth 
Lyon  and Miss Vanessa Merry for valuable technical assistance. 
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